Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2025 Rank: 2257
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 207 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2257 | 2505 |
| Total Cites | 49689 | 52817 |
| H-index | 98 | 105 |
| Hm-index | 39 | 39 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 1036 | 1041 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 14298 | 14592 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 28714 | 30195 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 32443 | 33378 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.58 |
| Self-Citation Percentage |
5.92%
|
|
Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2022 Rank: 1621
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 169 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1621 | 1879 |
| Total Cites | 44455 | 47443 |
| H-index | 95 | 99 |
| Hm-index | 38 | 39 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 968 | 973 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 13834 | 14127 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 27011 | 28482 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 28050 | 28873 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.64 |
| Self-Citation Percentage |
6.30%
|
|
Bredt, David S.
Janssen Pharmaceuticals Research & Development,
United States
2021 Rank: 1535
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 159 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1535 | 1794 |
| Total Cites | 43292 | 46187 |
| H-index | 94 | 97 |
| Hm-index | 37 | 38 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 948 | 953 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 13612 | 13903 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 26393 | 27834 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27322 | 28100 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.64 |
| Self-Citation Percentage |
6.27%
|
|
Bredt, David S.
Johnson & Johnson Pharmaceutical Research & Development, Raritan,
United States
2020 Rank: 1342
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Developmental Biology
Rank in SubField 1: 144 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1342 | 1547 |
| Total Cites | 41969 | 44807 |
| H-index | 91 | 94 |
| Hm-index | 37 | 38 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 912 | 917 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 13399 | 13690 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 25563 | 26970 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26428 | 27193 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.65 |
| Self-Citation Percentage |
6.33%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.